Surgery Doctors in Corona, CA Accepting Medicare

7 Surgery doctors found. Showing 1 - 7

Dr. Massimo Arcerito, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 21634 Retreat Pkwy, Corona, CA 92883 Phone: 951-278-8870    Fax: 951-278-8913

Mr. Terry L Sanderfer, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2250 S Main St Ste 106, Corona, CA 92882 Phone: 951-371-2703    Fax: 951-371-9348

Dr. John Emil Kaiser, M.D. Surgery - Vascular Surgery Medicare: Accepting Medicare Assignments Practice Location: 1820 Fullerton Ave, #120, Corona, CA 92881 Phone: 951-371-4400    Fax: 951-273-0719

Dr. David Yongsuk Suh, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2083 Compton Ave, Suite 104, Corona, CA 92881 Phone: 951-256-8191    Fax: 951-256-8190

Dr. Michael Fayez Sedrak, MD Surgery Medicare: May Accept Medicare Assignments Practice Location: 1902 Fullerton Ave Ste 101, Corona, CA 92881 Phone: 951-479-8994    Fax: 619-209-7888

Erin Huan Lin, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 13346 Wagon Creek Way, Corona, CA 92880 Phone: 951-264-2193    Fax: 909-580-1363

Dr. Ama Lindiwe Lacy, MD Surgery Medicare: Medicare Enrolled Practice Location: 13380 Goldenhorn Dr, Corona, CA 92883 Phone: 951-310-3075    Fax: 951-602-6666

News Archive

Bathroom scale model of weight loss most effective

According to a researcher in the U.S. losing and keeping off weight requires a lifelong commitment and effort.

SGO welcomes new options for detecting and preventing cervical cancer

The FDA approval of primary human papillomavirus (HPV) testing will provide doctors one more tool to use in cervical cancer screening, a health routine responsible for saving countless lives. As the largest organization of doctors specializing in the treatment of women's cancers, including cervical cancer, the Society of Gynecologic Oncology welcomes new options for detecting and preventing this terrible disease.

Eleven Biotherapeutics announces completion of $35M Series A funding

Eleven Biotherapeutics, a biopharmaceutical company focused on translating breakthrough discoveries from science and medicine to engineer and develop innovative protein-based therapeutics, announced today it has completed a $35 million Series A financing co-led by Flagship Ventures and Third Rock Ventures. Proceeds from the financing will be used to build the research and development and business development teams for Eleven Biotherapeutics, in addition to advancing the company's portfolio of engineered proteins through clinical proof of concept.

Frequent surveillance imaging not associated with improved overall postoperative survival

Cancer treatment continues to improve for many types of cancer, leading to increased life expectancy for many survivors.

Read more Medical News

› Verified 1 days ago